Jean‐Pierre Amorij

发表

Current and next generation influenza vaccines: Formulation and production strategies.

P. Soema, R. Kompier, Jean‐Pierre Amorij, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes

L. A. van der Pol, Jean‐Pierre Amorij, G. Kersten, 2016, PloS one.

Buccal and sublingual vaccine delivery

Jean-Pierre Amorij, Gideon Kersten, Wim Jiskoot, 2014, Journal of Controlled Release.

Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.

W. Hinrichs, H. Frijlink, Jean‐Pierre Amorij, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Minipigs as an animal model for dermal vaccine delivery.

Jean‐Pierre Amorij, G. Kersten, S. V. van Kuijk, 2014, Comparative medicine.

Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.

W. Hinrichs, H. Frijlink, A. Huckriede, 2007, Vaccine.

A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus.

W. Jiskoot, J. Bouwstra, Jean‐Pierre Amorij, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG

Jean‐Pierre Amorij, G. Kersten, R. ten Have, 2016, PloS one.

Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses

C. Boog, P. Soema, Jean‐Pierre Amorij, 2014, PloS one.

Alternative delivery of a thermostable inactivated polio vaccine.

Jean‐Pierre Amorij, G. Kersten, C. Löwik, 2015, Vaccine.

Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.

W. Jiskoot, Jean‐Pierre Amorij, G. Kersten, 2012, Vaccine.

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

W. Hinrichs, H. Frijlink, A. Huckriede, 2010, The AAPS Journal.

Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization

H. Frijlink, P. Soema, Jean‐Pierre Amorij, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model.

W. Hinrichs, H. Frijlink, A. Huckriede, 2007, Vaccine.

Pulmonary vaccine delivery: a realistic approach?

W. Hinrichs, H. Frijlink, Jean‐Pierre Amorij, 2012, Journal of aerosol medicine and pulmonary drug delivery.

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes

W. Jiskoot, R. Jacobi, J. van Beek, 2018, Front. Immunol..

The effect of formulation on spray dried Sabin inactivated polio vaccine

H. Frijlink, P. Soema, Jean‐Pierre Amorij, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Intranasal and sublingual delivery of inactivated polio vaccine.

P. Soema, Jean‐Pierre Amorij, G. Kersten, 2017, Vaccine.

Development of Thermostable Lyophilized Inactivated Polio Vaccine

Jean‐Pierre Amorij, G. Kersten, H. Kraan, 2014, Pharmaceutical Research.

A New Strategy to Stabilize Oxytocin in Aqueous Solutions: I. The Effects of Divalent Metal Ions and Citrate Buffer

W. Hinrichs, H. Frijlink, W. Jiskoot, 2011, The AAPS Journal.

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine

W. Jiskoot, P. Soema, Jean‐Pierre Amorij, 2014, Pharmaceutical Research.

The development of stable influenza vaccine powder formulations for new needle-free dosage forms

W. Hinrichs, H. Frijlink, A. Huckriede, 2007 .

Development of stable influenza vaccine powder formulations for non-parenteral dosage forms: challenges and possibilities

W. Hinrichs, H. Frijlink, J. Wilschut, 2007 .

Developments in the formulation and delivery of spray dried vaccines

H. Frijlink, P. Soema, Jean‐Pierre Amorij, 2017, Human vaccines & immunotherapeutics.

A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.

Jean-Pierre Amorij, Gideon F A Kersten, Henderik W Frijlink, 2016, International journal of pharmaceutics.

The development of stable influenza vaccine powder formulations for new needle-free dosage forms

W. Hinrichs, H. Frijlink, T. Stegmann, 2017 .

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

W. Hinrichs, H. Frijlink, J. Wilschut, 2008, Pharmaceutical Research.

Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.

Jean-Pierre Amorij, Wim Jiskoot, W. Jiskoot, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Towards tailored vaccine delivery: needs, challenges and perspectives.

W. Hinrichs, W. Jiskoot, J. Bouwstra, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

W. Hinrichs, H. Frijlink, J. Wilschut, 2010, The AAPS Journal.

Needle-free influenza vaccination.

W. Hinrichs, H. Frijlink, J. Wilschut, 2010, The Lancet. Infectious diseases.

Vaccine Development: History, Current Status, and Future Trends

Leo A. van der Pol, Jean-Pierre Amorij, Jean‐Pierre Amorij, 2013 .

Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.

W. Hinrichs, H. Frijlink, J. Wilschut, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Development of Thermostable Lyophilized Inactivated Polio Vaccine

Jean‐Pierre Amorij, G. Kersten, H. Kraan, 2014, Pharmaceutical Research.

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses

P. Soema, Jean‐Pierre Amorij, G. Kersten, 2015, Front. Immunol..

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low- and middle-income countries: a modelling study

M. Jit, Jean‐Pierre Amorij, C. Gregory, 2023, medRxiv.

Estimating the future global dose demand for measles–rubella microarray patches

T. Cherian, M. Meltzer, D. Durrheim, 2022, Frontiers in Public Health.

Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities

Jean‐Pierre Amorij, B. Giersing, C. Jarrahian, 2023, Expert opinion on drug delivery.

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges

D. Durrheim, N. Crowcroft, P. Gilbert, 2022, Frontiers in Public Health.

Preservation of Influenza Virosome Structure and Function During Freeze-Drying and Storage

W. Hinrichs, H. Frijlink, J. Wilschut, 2007, Journal of liposome research.

A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.

H W Frijlink, A H de Boer, W. Hinrichs, 2010, Journal of controlled release : official journal of the Controlled Release Society.

The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production

H. Frijlink, A. Bakker, Jean‐Pierre Amorij, 2016, PloS one.

The Production of a Stable Infliximab Powder

A. Bakker, Jean‐Pierre Amorij, G. Kersten, 2019 .

Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries

Jean‐Pierre Amorij, Anna-Léa Kahn, B. Giersing, 2021, Vaccine.

Alternative administration routes and delivery technologies for polio vaccines

Jean‐Pierre Amorij, G. Kersten, H. Kraan, 2016, Expert review of vaccines.

Bioneedles as alternative delivery system for hepatitis B vaccine.

Jean‐Pierre Amorij, G. Kersten, H. Kraan, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Formulation of influenza T cell peptides : in search of a universal influenza vaccine

C. Boog, P. Soema, Jean‐Pierre Amorij, 2015 .

Whole inactvated influenza virus as an adjuvant for influenza peptide antigens

W. Jiskoot, J. V. Beek, Jean‐Pierre Amorij, 2015 .

Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization

H. Frijlink, Jean‐Pierre Amorij, G. Kersten, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.

W. Hinrichs, H. Frijlink, Jean‐Pierre Amorij, 2014, European Journal of Pharmaceutical Sciences.

Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.

W. Jiskoot, Jean‐Pierre Amorij, G. Kersten, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Formulation of influenza T cell peptides : in search of a universal influenza vaccine

C. Boog, Jean‐Pierre Amorij, G. Kersten, 2015 .

The development of stable influenza vaccine powder formulations for new needle-free dosage forms

Jean‐Pierre Amorij, 2008 .

Influenza T cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine

Jean‐Pierre Amorij, G. Kersten, G. Willems, 2015 .

Current and next generation inﬂuenza vaccines: Formulation and production strategies

Jean‐Pierre Amorij, G. Kersten, Peter Soema, 2022 .

A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.

H. Frijlink, Jean‐Pierre Amorij, G. Kersten, 2016, International journal of pharmaceutics.